Patient Management

2074 soru

Soru 1701Soru →

A 7878-year-old woman is brought to the emergency department from a skilled nursing facility due to severe abdominal pain and altered mental status. Staff report that she has had progressive abdominal distention, nausea, and no bowel movements for the past 33 days. Her past medical history is significant for Parkinson disease, chronic constipation, and moderate Alzheimer dementia. Her temperature is 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), pulse is 122/min122/\text{min}, blood pressure is 85/55 mmHg85/55\text{ mmHg}, and respirations are 24/min24/\text{min}. Physical examination reveals a massively distended abdomen that is diffusely tender to palpation, with severe rigidity and involuntary guarding. Bowel sounds are absent. Laboratory studies show a leukocyte count of 18,500/mm318,500/\text{mm}^3 and a serum lactate level of 4.8 mmol/L4.8\text{ mmol/L}. An upright abdominal radiograph demonstrates a markedly dilated loop of colon extending from the pelvis to the right upper quadrant in an inverted U-shape, lacking haustra. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Emergent exploratory laparotomy

Cevap

Emergent exploratory laparotomy
The correct intervention is emergent exploratory laparotomy. This patient's presentation of massive abdominal distention, obstipation, and an inverted U-shaped loop of colon on radiography is diagnostic of sigmoid volvulus. While the textbook initial step for an uncomplicated sigmoid volvulus is endoscopic detorsion via flexible sigmoidoscopy, this patient has signs of a complicated volvulus: peritonitis (rigidity, involuntary guarding), bowel ischemia (lactic acidosis), and septic shock (fever, tachycardia, hypotension). In this setting, endoscopic detorsion is strictly contraindicated due to the high risk of perforation and failure to remove necrotic bowel. Immediate surgical exploration (often involving resection of the necrotic sigmoid colon and creation of an end colostomy, known as a Hartmann's procedure) is life-saving and necessary.

Adım Adım Çözüm

1
Analyze the clinical presentation and vital signs.
The patient has septic shock (hypotension, tachycardia, fever) and an acute abdomen (rigidity, guarding) with elevated lactate.
Identifying the severity of the patient's condition dictates whether management can be conservative, diagnostic, or requires immediate surgical intervention.
2
Correlate the physical findings with the radiographic evidence.
An inverted U-shape ('coffee bean' sign) lacking haustra is classic for sigmoid volvulus. Combined with peritonitis, this indicates complicated sigmoid volvulus with likely bowel ischemia or impending perforation.
Connecting the specific anatomical obstruction to the systemic inflammatory response confirms the exact etiology of the acute abdomen.
3
Determine the optimal procedural intervention.
Select exploratory laparotomy, bypassing non-operative endoscopic detorsion.
Endoscopic detorsion is contraindicated when peritonitis or bowel ischemia is present; surgical resection of the necrotic colon segment is required.

Anahtar Kavram

Patients with sigmoid volvulus who exhibit signs of peritonitis, bowel ischemia, or perforation require immediate exploratory laparotomy, whereas those with uncomplicated presentations can safely undergo endoscopic detorsion.
Soru 1702Soru →

A 52-year-old man comes to the clinic due to a new-onset tremor and headaches over the past 3 days. He underwent a deceased-donor renal transplantation 8 months ago for end-stage renal disease secondary to hypertensive nephrosclerosis. His maintenance immunosuppression regimen consists of tacrolimus, mycophenolate mofetil, and low-dose prednisone. Two weeks ago, he was diagnosed with esophageal candidiasis by his primary care physician and was started on a 14-day course of oral fluconazole. His temperature is 37.1°C (98.8°F), blood pressure is 168/95 mmHg (baseline 125/80 mmHg), and heart rate is 82/min. Physical examination reveals a fine resting tremor in both hands. The renal allograft is non-tender to palpation.

Laboratory studies show:
Blood urea nitrogen: 42 mg/dL
Serum creatinine: 2.7 mg/dL (baseline 1.3 mg/dL)
Serum potassium: 5.2 mEq/L
Urinalysis: Trace protein, no red blood cells, no white blood cells

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Measure serum tacrolimus trough level and withhold the next dose

Cevap

The most appropriate next step is to measure the serum tacrolimus trough level and withhold the next dose.
The correct answer is to measure the serum tacrolimus trough level and withhold the next dose. This patient's clinical presentation—acute kidney injury (AKI), new-onset hypertension, and neurologic symptoms (tremor, headaches)—is highly characteristic of calcineurin inhibitor (CNI) toxicity. Tacrolimus is heavily metabolized in the liver and intestines by the cytochrome P450 3A4 (CYP3A4) enzyme system. Fluconazole is a well-known, potent inhibitor of CYP3A4. When fluconazole was initiated for esophageal candidiasis, it significantly decreased the clearance of tacrolimus, leading to supratherapeutic serum levels. Elevated tacrolimus levels cause potent afferent arteriolar vasoconstriction, leading to acute nephrotoxicity and hypertension. Neurotoxicity is another classic dose-dependent side effect. The most appropriate next step in monitoring and management is to measure the serum tacrolimus trough level to confirm toxicity and immediately withhold the medication. Once the level falls back into the therapeutic range, tacrolimus can be restarted at a lower, carefully monitored dose while the patient completes the fluconazole course.

Adım Adım Çözüm

1
Analyze the patient's presentation and longitudinal data.
The patient developed acute kidney injury, new-onset hypertension, and neurotoxicity (tremor, headaches) shortly after starting fluconazole.
Identifying temporal relationships between new medications and symptom onset is critical in transplant patients.
2
Identify the pharmacological interaction.
Fluconazole strongly inhibits the CYP3A4 enzyme, which is responsible for the metabolism of tacrolimus.
Decreased metabolism leads to the toxic accumulation of tacrolimus in the serum.
3
Determine the appropriate management protocol.
The immediate priority is to confirm the suspected toxicity via drug levels and stop further accumulation by withholding the drug.
Checking the trough level confirms the diagnosis, and withholding the dose prevents worsening of the acute kidney injury and neurotoxicity.

Anahtar Kavram

Calcineurin inhibitor toxicity (e.g., tacrolimus) often presents with acute kidney injury, hypertension, and neurotoxicity, and can be precipitated by CYP3A4 inhibitors like azole antifungals. The initial management is to check trough levels and withhold the offending drug.
Tahmini Süre:1m 30s
Soru 1703Soru →

A 64-year-old woman is evaluated in the surgical intensive care unit for a rapidly declining platelet count. Seven days ago, she underwent a complex coronary artery bypass grafting procedure. Her postoperative course was initially uncomplicated, and she has been receiving subcutaneous unfractionated heparin for deep vein thrombosis prophylaxis. Today, her platelet count is 55,000/μL, representing a 65% drop from her baseline of 180,000/μL. Examination reveals a new, painful, swollen right lower extremity. Venous duplex ultrasonography confirms an acute right popliteal deep vein thrombosis. A clinical diagnosis of heparin-induced thrombocytopenia (HIT) is suspected based on a 4T score of 6 (high probability). Arrange the following management and monitoring steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first discontinue all heparin products, then draw diagnostic labs for PF4 antibodies, empirically initiate a non-heparin anticoagulant (argatroban), monitor its efficacy via aPTT, and finally transition to warfarin only once the platelet count has fully recovered.
The standard of care for patients with high-probability HIT (4T score ≥ 4) mandates the immediate discontinuation of all heparin. Because HIT is strongly prothrombotic, cessation alone is insufficient; a fast-acting non-heparin anticoagulant (e.g., argatroban, bivalirudin, or fondaparinux) must be initiated empirically. Blood for diagnostic testing (PF4 ELISA) should be drawn just prior to starting the new anticoagulant. The new agent must be meticulously monitored (e.g., aPTT for argatroban). Finally, transition to a vitamin K antagonist (warfarin) must strictly be delayed until the platelet count has recovered (typically ≥ 150,000/μL) to avoid the catastrophic complication of venous limb gangrene resulting from early protein C depletion.

Adım Adım Çözüm

1
Stop all heparin exposure.
Halts the formation of heparin-PF4-antibody immune complexes.
Continuing heparin fuels the underlying pathophysiology of platelet activation and thrombosis.
2
Send HIT panel (PF4 ELISA) laboratory tests.
Secures the diagnostic sample.
Must be done promptly to confirm the clinical suspicion, but empirical treatment should not wait for the result.
3
Start argatroban (or another non-heparin anticoagulant).
Provides immediate alternative anticoagulation.
The patient has a confirmed new DVT and is in a hypercoagulable state; therapeutic anticoagulation is mandatory.
4
Titrate argatroban using serial aPTT monitoring.
Maintains the drug within the narrow therapeutic window.
Ensures efficacy against clot extension while preventing iatrogenic bleeding.
5
Initiate warfarin once platelets are ≥ 150,000/μL.
Safely bridges the patient to long-term oral therapy.
Early warfarin causes a transient, severe hypercoagulable state due to the rapid decline of protein C, risking venous limb gangrene if given before HIT resolves.

Anahtar Kavram

Management of high-probability heparin-induced thrombocytopenia (HIT) requires immediate cessation of heparin, prompt empiric initiation of a non-heparin anticoagulant, close monitoring of therapeutic levels, and delayed initiation of warfarin until platelet recovery.
Soru 1704Soru →

A 67-year-old woman is evaluated in the cardiology clinic for a three-month history of episodic chest heaviness. She reports that the discomfort occurs when she performs upper body exertion, such as vacuuming or carrying groceries, and resolves completely after approximately five minutes of rest. Her medical history is significant for type 2 diabetes mellitus, hypertension, hyperlipidemia, advanced bilateral knee osteoarthritis, and severe persistent asthma. She relies on a motorized scooter for mobility due to debilitating joint pain. Her respiratory regimen includes a daily high-dose fluticasone-salmeterol inhaler and oral montelukast, but she still requires albuterol rescue therapy three to four times a week. Vital signs include a blood pressure of 146/88146/88 mm Hg and a heart rate of 7676/min. Physical examination reveals bilateral end-expiratory wheezes and pronounced crepitus in both knees. The cardiac examination is unremarkable. Her baseline electrocardiogram displays normal sinus rhythm without ischemic changes or conduction delays. Which of the following is the most appropriate next step in diagnostic workup?

Cevabı ve açıklamayı göster

Cevap: Dobutamine stress echocardiography

Cevap

Dobutamine stress echocardiography
The correct next step is dobutamine stress echocardiography. This patient has classic symptoms of stable angina and requires a non-invasive stress test to assess for inducible myocardial ischemia. Because her severe knee osteoarthritis renders her unable to exercise on a treadmill, a pharmacologic stress test is required. The two primary modalities for pharmacologic stress testing are vasodilator agents (e.g., adenosine, dipyridamole) and inotropic agents (e.g., dobutamine). Vasodilator agents are strictly contraindicated in patients with severe, active reactive airway disease because they stimulate bronchial adenosine receptors and can induce life-threatening bronchospasm. Given her active wheezing and frequent albuterol use, dobutamine is the safest pharmacologic agent to simulate stress and evaluate for regional wall motion abnormalities via echocardiography.

Adım Adım Çözüm

1
Identify the clinical syndrome and pre-test probability.
The patient's exertional chest heaviness resolving with rest indicates typical stable angina, requiring further risk stratification for coronary artery disease.
To determine whether immediate invasive intervention or non-invasive diagnostic testing is warranted.
2
Assess the patient's capacity for physical exertion.
The patient uses a motorized scooter due to severe bilateral knee osteoarthritis and cannot perform a treadmill exercise test.
To choose between a physiological exercise stress test and a pharmacologic stress test.
3
Evaluate for contraindications to specific pharmacologic stress agents.
The patient has active, severe persistent asthma with wheezing on examination, which is an absolute contraindication to vasodilator agents (adenosine, dipyridamole).
To prevent potentially life-threatening iatrogenic bronchospasm.
4
Select the safest and most appropriate testing modality.
Dobutamine stress echocardiography is identified as the optimal diagnostic test.
Dobutamine serves as a safe inotropic alternative to vasodilators, and echocardiography will adequately assess for stress-induced regional wall motion abnormalities.

Anahtar Kavram

Selection of the appropriate non-invasive stress testing modality based on patient-specific physical limitations and pharmacologic contraindications.
Soru 1705Soru →

A 76-year-old woman is admitted to the hospital from the emergency department due to a 3-day history of a productive cough, fever, and worsening shortness of breath. Her past medical history is significant for hypertension, type 2 diabetes mellitus, and major depressive disorder. Her current medications include lisinopril, metformin, and citalopram. She has a documented allergy to amoxicillin, which caused a maculopapular rash on her trunk when she was a teenager; she has never experienced anaphylaxis, wheezing, or lip swelling.

Vital signs include a temperature of 38.7∘C38.7^\circ\text{C} (101.7∘F101.7^\circ\text{F}), blood pressure of 118/74 mmHg118/74\text{ mmHg}, pulse of 102/min102/\text{min}, and respiratory rate of 26/min26/\text{min}. Pulse oximetry shows 91%91\% on room air. Physical examination reveals bronchial breath sounds and crackles in the right lower lung field. Laboratory studies show a leukocyte count of 14,500/μL14,500/\mu\text{L} with 85%85\% neutrophils. Chest radiograph demonstrates a right lower lobe consolidation. An electrocardiogram obtained on admission shows normal sinus rhythm with a QTc interval of 495 ms495\text{ ms}.

Which of the following is the most appropriate empiric pharmacologic intervention for this patient?

Cevabı ve açıklamayı göster

Cevap: Ceftriaxone and doxycycline

Cevap

The most appropriate regimen is ceftriaxone and doxycycline. This provides necessary typical and atypical microbial coverage while avoiding QTc prolongation in a patient with a high baseline QTc and concurrent citalopram use.
The correct regimen perfectly balances empiric coverage for inpatient community-acquired pneumonia (CAP) with vital safety constraints. Inpatient CAP requires coverage for both typical (Streptococcus pneumoniae, Haemophilus influenzae) and atypical (Mycoplasma, Legionella) pathogens. Standard regimens include a beta-lactam plus a macrolide, or a respiratory fluoroquinolone. However, this patient's QTc interval is significantly prolonged at 495 ms, and she is taking citalopram, an SSRI known to independently prolong the QTc. Administering azithromycin or levofloxacin would unacceptably increase her risk of Torsades de pointes. Doxycycline provides excellent atypical coverage without affecting ventricular repolarization. Furthermore, her childhood history of a maculopapular rash to amoxicillin does not preclude the use of ceftriaxone, as cross-reactivity is less than 1% and the original reaction was not IgE-mediated (anaphylactic).

Adım Adım Çözüm

1
Diagnose the clinical condition and determine the required treatment setting.
The patient has community-acquired pneumonia (CAP) requiring inpatient admission (based on age, vital signs, and oxygen saturation).
Establishing the severity and setting dictates the empiric antibiotic guidelines (e.g., inpatient ward requires beta-lactam plus a macrolide, or a respiratory fluoroquinolone).
2
Evaluate the patient's allergy history to select a safe primary agent for typical pathogens.
The patient has a history of a childhood maculopapular rash to amoxicillin. A third-generation cephalosporin like ceftriaxone is safe.
A maculopapular rash is not an IgE-mediated anaphylactic reaction. The cross-reactivity between penicillins and third-generation cephalosporins is extremely low, making ceftriaxone the standard of care over unnecessarily avoiding all beta-lactams.
3
Assess the patient's medication list and ECG findings for potential contraindications to standard atypical coverage options.
The patient is taking citalopram and has a baseline QTc interval of 495 ms. Macrolides (azithromycin) and fluoroquinolones (levofloxacin) must be avoided.
Citalopram is known to cause dose-dependent QTc prolongation. Using a macrolide or fluoroquinolone in a patient with an already prolonged QTc (>460 ms in women) significantly increases the risk of life-threatening Torsades de pointes.
4
Select the optimal regimen that fulfills both microbiologic requirements and patient safety constraints.
Doxycycline is chosen for atypical coverage because it does not prolong the QTc interval.
Combining ceftriaxone and doxycycline perfectly addresses the infectious etiology of CAP while navigating the patient's low-risk penicillin allergy and high-risk cardiac electrical profile.

Anahtar Kavram

Pharmacologic selection in community-acquired pneumonia must integrate antimicrobial spectrum guidelines with patient-specific safety profiles, particularly avoiding QTc-prolonging antibiotics (macrolides, fluoroquinolones) in high-risk patients and appropriately utilizing cephalosporins in non-anaphylactic penicillin allergies.
Soru 1706Soru →

Correlate the following specific clinical risk profiles and functional assessments with their optimal disposition or care transition setting according to standard medical guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old with community-acquired pneumonia, a respiratory rate of 16/min, blood urea nitrogen of 12 mg/dL, and normal mentation.
A 55-year-old requiring 6 weeks of intravenous ceftriaxone for uncomplicated vertebral osteomyelitis, completely independent with activities of daily living.
A 78-year-old stabilized 6 days post-ischemic stroke with significant left-sided hemiparesis, lacking the physical endurance to participate in 3 hours of daily rehabilitation.
A 62-year-old with acute asthma exacerbation who develops progressive hypercapnia, altered mental status, and impending respiratory muscle fatigue despite maximal medical therapy.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The pneumonia patient (CURB-65 of 0) pairs with home discharge on oral therapy; the osteomyelitis patient pairs with OPAT; the stroke patient lacking endurance pairs with SNF; and the asthma patient with impending failure pairs with ICU.
Each disposition choice is driven by established criteria: CURB-65 scores of 0-1 indicate outpatient safety; OPAT is standard for stable patients needing prolonged IV antibiotics; SNF placement is indicated for patients needing skilled nursing or therapy who cannot tolerate the rigorous 3-hour daily requirement of an IRF; and impending respiratory failure with hypercapnia requires ICU-level care.

Adım Adım Çözüm

1
Evaluate the 45-year-old with community-acquired pneumonia.
Calculated CURB-65 score is 0.
Determining objective pneumonia severity guides the appropriate level of care required.
2
Assess the 55-year-old with osteomyelitis.
Patient requires prolonged IV antibiotics but is hemodynamically stable and independent.
Stable patients requiring extended IV therapy can safely avoid prolonged hospital stays through outpatient programs.
3
Analyze the disposition needs for the 78-year-old post-stroke patient.
Patient needs rehabilitation but lacks endurance for 3 hours of daily therapy.
Inpatient Rehabilitation Facilities (IRF) require 3 hours of daily therapy tolerance; a Skilled Nursing Facility (SNF) is appropriate for those who cannot tolerate this intensity.
4
Assess the 62-year-old with asthma exacerbation.
Patient shows hypercapnia, altered mental status, and fatigue.
These are clinical signs of impending respiratory failure requiring advanced airway management and intensive monitoring.

Anahtar Kavram

Appropriate patient disposition requires synthesizing objective severity scores (e.g., CURB-65), functional capacity assessments (e.g., therapy endurance), and ongoing clinical needs (e.g., IV therapy, airway management).
Soru 1707Soru →

A 48-year-old male presents to the clinic complaining of excessive sweating, diffuse joint pain, and a gradual increase in his shoe size over the past three years. He also mentions that he recently had to have his wedding ring resized because it would no longer fit over his knuckle. On physical examination, his blood pressure is 148/92 mm Hg. He is noted to have coarse facial features, a prominent mandible, macroglossia, and enlarged, doughy hands. The physician strongly suspects an underlying endocrine disorder characterized by hormonal hypersecretion.

Assuming each step confirms the progression of the diagnostic pathway, arrange the following clinical evaluations in the most appropriate sequential order to screen for, confirm, localize, and assess the local complications of this patient's suspected condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct diagnostic sequence begins with biochemical screening via serum IGF-1, followed by dynamic confirmation using an OGTT with GH measurement, anatomical localization via pituitary MRI, and finally, assessment of local mass effects using formal visual field testing.
The diagnostic workup for acromegaly represents a classic paradigm of endocrinologic test sequencing. Because random growth hormone (GH) levels fluctuate widely due to pulsatile secretion, the workup must begin with serum Insulin-like Growth Factor 1 (IGF-1), which provides a stable, integrated marker of overall GH activity. If the IGF-1 level is elevated (adjusting for age and sex), the diagnosis must be confirmed dynamically with an Oral Glucose Tolerance Test (OGTT). Normal physiology dictates that a glucose load should suppress GH to very low levels; failure to suppress confirms autonomous GH production. Only after this biochemical confirmation is secured should anatomical imaging (MRI of the sella turcica) be pursued. Premature imaging risks discovering a clinically silent pituitary 'incidentaloma,' which could falsely anchor the diagnosis. Finally, once a central mass is confirmed, assessing for local anatomical complications—specifically optic chiasm compression—via formal visual field testing completes the comprehensive diagnostic workup prior to surgical planning.

Adım Adım Çözüm

1
Select the most appropriate initial biochemical screening test.
Measurement of serum IGF-1 concentration.
Growth hormone is secreted in a highly pulsatile manner, making random serum GH levels unreliable. IGF-1 mediates most of the effects of GH and has a long half-life, providing a stable reflection of average GH secretion.
2
Select the definitive dynamic confirmatory test.
Measurement of serum GH levels following an oral glucose load.
In normal physiology, a glucose load suppresses GH secretion. In autonomous hypersecretion (acromegaly), this suppression fails. This test confirms the biochemical diagnosis.
3
Identify the anatomical source of the hypersecretion.
Magnetic resonance imaging (MRI) of the sella turcica.
Greater than 95% of acromegaly cases are caused by a GH-secreting pituitary adenoma. Imaging should only be ordered after biochemical confirmation to avoid the diagnostic confusion caused by incidental, non-functioning pituitary microadenomas.
4
Assess for local complications related to the identified anatomical lesion.
Formal automated perimetry (visual field testing).
Pituitary macroadenomas frequently extend suprasellar and compress the optic chiasm. Visual field testing evaluates for neurological deficits (e.g., bitemporal hemianopsia) which can dictate the urgency of surgical intervention.

Anahtar Kavram

The diagnostic sequencing for suspected functional endocrine tumors (such as acromegaly) strictly follows three phases: 1) biochemical screening with a stable marker, 2) dynamic biochemical confirmation, and 3) anatomical localization and complication assessment.
Tahmini Süre:1m 30s
Soru 1708Soru →

A 45-year-old man comes to the clinic for a routine follow-up. He has a 5-year history of bipolar I disorder, which has been well-controlled on lithium monotherapy. He has not experienced a manic or depressive episode since starting this medication. Over his last three clinic visits, his blood pressure has been consistently elevated, averaging 154/92154/92 mm Hg. He has strictly adhered to a low-sodium diet and a regular aerobic exercise program for the past 6 months without significant improvement in his blood pressure. His body mass index is 2626 kg/m 2^2. The remainder of his physical examination is unremarkable. Laboratory studies reveal a serum creatinine of 0.90.9 mg/dL and a serum lithium level of 0.80.8 mEq/L (therapeutic range: 0.6−1.20.6-1.2 mEq/L). A decision is made to initiate pharmacologic therapy for his essential hypertension. Which of the following is the most appropriate initial antihypertensive medication for this patient?

Cevabı ve açıklamayı göster

Cevap: Amlodipine

Cevap

Amlodipine is the most appropriate initial antihypertensive medication for a patient on lithium.
The correct answer is amlodipine. It is a dihydropyridine calcium channel blocker and is considered a first-line antihypertensive agent. Importantly, it does not significantly alter lithium clearance or increase the risk of neurotoxicity, making it the safest and most appropriate choice for a patient stabilized on lithium therapy.

Adım Adım Çözüm

1
Evaluate the indication for pharmacotherapy.
The patient has essential hypertension refractory to lifestyle modifications, requiring medical therapy.
Sustained blood pressure elevation above guideline thresholds warrants intervention to reduce long-term cardiovascular risk.
2
Identify the patient's existing medications and potential drug interactions.
The patient is on lithium. Thiazide diuretics, ACE inhibitors, ARBs, and non-dihydropyridine CCBs must be avoided.
Thiazides and ACE inhibitors/ARBs decrease lithium clearance, leading to toxicity. Non-dihydropyridine CCBs increase the risk of severe neurotoxicity.
3
Select the safest first-line antihypertensive agent.
Amlodipine is selected as the initial therapy.
Amlodipine is a dihydropyridine CCB, which is a first-line agent for essential hypertension and does not adversely interact with lithium.

Anahtar Kavram

In patients taking lithium, first-line antihypertensive agents such as thiazide diuretics and ACE inhibitors/ARBs must be avoided as they decrease lithium clearance and precipitate toxicity. Dihydropyridine calcium channel blockers (e.g., amlodipine) are safe and effective alternatives.
Soru 1709Soru →

An emergency physician evaluates a 62-year-old man who reports three days of progressively worsening left lower abdominal pain accompanied by fever and chills. His medical history is significant for hypertension and hyperlipidemia, both well-controlled with medications. His temperature is 38.7°C (101.7°F), blood pressure is 134/82 mm Hg, pulse is 105/min, and respiratory rate is 16/min. Physical examination demonstrates marked tenderness and guarding over the left lower quadrant, but the abdomen is otherwise soft without diffuse rigidity or generalized rebound tenderness. Laboratory studies show a leukocyte count of 16,500/mm³ with 82% neutrophils. A contrast-enhanced computed tomography scan of the abdomen and pelvis reveals inflammatory changes adjacent to the sigmoid colon, complicated by a well-defined, 5.2-cm unilocular pericolic fluid collection with an enhancing rim. There is no evidence of free intraperitoneal air. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Image-guided percutaneous drainage

Cevap

Image-guided percutaneous drainage
The correct intervention is image-guided percutaneous drainage because the patient has acute complicated diverticulitis with a large, localized abscess. In hemodynamically stable patients lacking signs of generalized peritonitis, percutaneous drainage (typically CT-guided) combined with intravenous antibiotics is the standard of care. This approach achieves immediate source control while avoiding the significant morbidity of an emergent bowel resection. Once the acute episode resolves, an elective single-stage colon resection can safely be performed.

Adım Adım Çözüm

1
Analyze the clinical presentation and imaging results.
The patient has acute sigmoid diverticulitis complicated by a 5.2-cm pericolic abscess, but remains hemodynamically stable without generalized peritonitis.
Establishing the exact stage and severity of complicated diverticulitis is necessary to select the correct intervention.
2
Determine the indication for intervention based on abscess size.
Fluid collections greater than 3 to 4 cm require active source control, typically via drainage.
Antibiotics alone have a high failure rate for larger abscesses, risking progressive sepsis or rupture.
3
Select the optimal procedural approach for source control.
Percutaneous drainage is preferred over surgical resection in a stable patient with a well-defined, accessible abscess.
Percutaneous drainage allows the acute inflammation to subside, converting a high-risk emergent operation (often requiring a colostomy) into a lower-risk elective single-stage resection weeks later.

Anahtar Kavram

The standard of care for acute diverticulitis complicated by a localized abscess larger than 3 cm in a stable patient is image-guided percutaneous drainage combined with intravenous antibiotics.
Soru 1710Soru →

A 54-year-old woman with a history of diffuse large B-cell lymphoma presents to the emergency department with chills and a temperature of 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}). She received her last cycle of cytotoxic chemotherapy 8 days ago. Laboratory studies show a white blood cell count of 700/mm3700/\text{mm}^3 with 30%30\% neutrophils (absolute neutrophil count: 210/mm3210/\text{mm}^3). She is hemodynamically stable, has a central venous port in place, and has no localizing signs of infection on physical examination. Arrange the following steps in the optimal sequence for the evaluation, monitoring, and therapeutic de-escalation of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The optimal sequence for managing high-risk febrile neutropenia begins with obtaining cultures, immediately administering broad-spectrum intravenous antibiotics, monitoring the ANC daily, transitioning to oral therapy when clinically stable and afebrile, and finally discontinuing antibiotics upon marrow recovery.
The standard of care for febrile neutropenia (fever ≥38.3∘C\ge 38.3^\circ\text{C} or sustained ≥38.0∘C\ge 38.0^\circ\text{C} for 1 hour with an ANC <500/mm3< 500/\text{mm}^3) dictates an immediate, step-wise approach. First, appropriate diagnostic tests (including blood cultures from all lumens of central lines and peripheral sites) must be obtained. Second, due to the risk of rapid clinical decline, empiric broad-spectrum intravenous antibiotics with antipseudomonal activity (e.g., cefepime, meropenem, piperacillin-tazobactam) must be administered within 1 hour. Third, the patient requires daily monitoring of the ANC and clinical status. Fourth, once the patient has been afebrile for at least 48 hours and demonstrates clinical stability, the regimen can be de-escalated from intravenous to oral antibiotics. Finally, all antimicrobial therapy can be safely discontinued once the ANC demonstrates sustained recovery to >500/mm3>500/\text{mm}^3.

Adım Adım Çözüm

1
Identify the patient as having high-risk febrile neutropenia.
The patient has an absolute neutrophil count (ANC) < 500/mm³ and a fever, requiring immediate intervention.
Febrile neutropenia is an oncologic emergency with high mortality if left untreated.
2
Sequence the diagnostic workup first.
Blood cultures must be drawn prior to administering any antibiotics.
Antibiotics rapidly sterilize the blood, making pathogen identification impossible if administered beforehand.
3
Sequence the initial acute treatment next.
Administer empiric intravenous antibiotics within 60 minutes of presentation.
Delays in broad-spectrum antibiotic administration significantly increase mortality in neutropenic patients.
4
Sequence the ongoing evaluation and monitoring.
Monitor daily ANC and fever curves.
The clinical response to empiric therapy must be tracked to guide future de-escalation decisions.
5
Sequence the initial therapeutic de-escalation.
Transition to oral antibiotics once the patient is afebrile for 48 hours.
Intravenous access is no longer strictly necessary once the patient is hemodynamically stable and defervesces, which reduces hospital length of stay and line-associated risks.
6
Sequence the final cessation step.
Discontinue all antibiotics when the ANC exceeds 500/mm³.
Once the immune system recovers sufficiently to fight off opportunistic infections, antimicrobial treatment can be safely stopped.

Anahtar Kavram

Monitoring and Treatment Evaluation in Febrile Neutropenia
Soru 1711Soru →

For each of the described post-acute recovery profiles, determine the most appropriate transition of care destination based on facility admission criteria and patient functional capacity.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 68-year-old who survived a pontine infarction, now medically stable with right-sided motor deficits. Demonstrates excellent cognitive reserve and easily tolerates comprehensive multidisciplinary therapeutic sessions lasting up to 4 hours per day.
A 75-year-old recovering from surgical fixation of a femur fracture. Pain is well-controlled, but the patient exhibits severe exhaustion after 45 minutes of physical therapy. Requires ongoing daily assistance with basic activities and complex wound monitoring.
A 61-year-old recovering from severe acute respiratory distress syndrome on day 24 of hospitalization. Alert and off vasopressors, but remains tracheostomy-dependent requiring specialized, protracted protocols for mechanical ventilation weaning.
A 52-year-old post-drainage of a deep neck space infection. Fully ambulatory and afebrile. Requires administration of intravenous ceftriaxone once daily for an additional 4 weeks. Lives with a capable, supportive partner.
An 85-year-old with end-stage heart failure experiencing dyspnea at rest despite maximum medical therapy. Has had four related admissions in the past two months and explicitly requests care focused exclusively on comfort.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Match the intensive stroke recovery to IRF, the easily fatigued post-operative patient to SNF, the stable ventilator-dependent patient to LTACH, the independent patient needing IV antibiotics to OPAT, and the end-stage heart failure patient to Hospice.
Safe and appropriate care transitions depend strictly on matching patient needs with specific facility capabilities. IRFs are reserved for intensive rehabilitation (>3 hrs/day). SNFs provide skilled nursing and lighter, slower-paced rehabilitation. LTACHs manage chronic critical illnesses like prolonged ventilator weaning. OPAT allows safe home administration of prolonged IV medications for otherwise stable patients. Hospice provides purely comfort-focused care for end-stage terminal conditions.

Adım Adım Çözüm

1
Assess the stroke patient's therapy tolerance and needs.
Requires multidisciplinary care and easily tolerates >3 hours of therapy per day.
This physical stamina differentiates eligibility for an Inpatient Rehabilitation Facility (requires 3+ hours) from a Skilled Nursing Facility.
2
Evaluate the post-fracture patient's stamina and medical needs.
Needs wound care but becomes exhausted after 45 minutes of therapy.
Confirms inability to participate in IRF programs, necessitating SNF placement for slower-paced rehabilitation and skilled nursing.
3
Analyze the ARDS patient's respiratory status.
Stable hemodynamically but remains tracheostomy-dependent and requires slow weaning after 24 days.
Prolonged ventilator weaning in an otherwise stabilized patient is the classic indication for Long-Term Acute Care Hospital admission.
4
Review the stable patient needing prolonged intravenous antibiotics.
Ambulatory, afebrile, and has strong social support at home.
Home health via OPAT is most appropriate and resource-efficient for isolated IV medication needs without other acute medical issues.
5
Determine the heart failure patient's prognosis and stated goals.
Refractory symptoms at rest, frequent admissions, and a desire for comfort-only measures.
Aligns perfectly with hospice criteria for end-of-life care.

Anahtar Kavram

Disposition and Care Setting Transitions
Soru 1712Soru →

Paramedics bring a 6262-year-old male to the emergency department after he experienced sudden-onset right-sided pleuritic chest pain and dyspnea. He currently resides in a local homeless shelter and has a history of essential hypertension. Upon arrival, his vital signs show a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 135/85 mm Hg135/85\text{ mm Hg}, heart rate of 92/min92\text{/min}, and respiratory rate of 18/min18\text{/min}. Pulse oximetry is 96%96\% on room air. Physical examination reveals mild right calf swelling and tenderness. Laboratory analysis demonstrates normal high-sensitivity troponin I and NT-proBNP levels, alongside normal renal function. A CT pulmonary angiogram confirms a small acute segmental pulmonary embolism in the right lower lobe. Transthoracic echocardiography reveals a normal right ventricle without evidence of strain. The patient's calculated Pulmonary Embolism Severity Index (PESI) score is 5555 (Class I, very low risk). Which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Admission to a medical observation unit for anticoagulation initiation and social services assessment

Cevap

Admission to a medical observation unit for anticoagulation initiation and social services assessment
While this patient has a low-risk pulmonary embolism that typically qualifies for outpatient management with a direct oral anticoagulant (DOAC), his unhoused status presents an absolute barrier to safe immediate discharge. DOACs are costly and require reliable pharmacy access. Discharging him to a shelter without ensuring medication-in-hand and establishing close follow-up poses an unacceptable risk of pulmonary embolism extension or fatal recurrence. Admission to a medical observation unit allows the multidisciplinary team (including social work and case management) to secure medication access and formulate a safe, reliable transition plan.

Adım Adım Çözüm

1
Stratify the medical severity of the pulmonary embolism.
The patient has a PESI score of 55 (Class I), normal hemodynamics, and no right heart strain.
Risk stratification dictates initial medical management; low-risk PE usually qualifies for outpatient management with a direct oral anticoagulant (DOAC).
2
Evaluate the patient's functional and psychosocial capacity for outpatient management.
The patient is unhoused and resides in a shelter.
Successful outpatient management requires medication adherence and reliable access to pharmacy services and follow-up care.
3
Synthesize medical and social data to determine the final care setting.
The social barriers (homelessness) override the low-risk medical score.
Prescribing an expensive medication to an unhoused patient without confirmed access poses an unacceptable risk of treatment failure. Admission/observation is required to involve social work and secure a safe transition plan.

Anahtar Kavram

Clinical risk scores must be integrated with a patient's psychosocial circumstances; severe social barriers (e.g., homelessness) often necessitate admission for care coordination even when medical scoring suggests outpatient management is safe.
Tahmini Süre:1m 30s
Soru 1713Soru →

A 72-year-old man is brought to the emergency department by ambulance due to the sudden onset of severe, tearing back pain and dizziness that began 30 minutes ago. His medical history is significant for hypertension, hyperlipidemia, and a 40-pack-year smoking history. Upon arrival, he appears pale, diaphoretic, and lethargic. His temperature is 36.5°C (97.7°F), blood pressure is 78/45 mm Hg, heart rate is 122/min, and respiratory rate is 22/min. Physical examination reveals a large, pulsatile mid-abdominal mass. Bedside ultrasonography demonstrates a 7.5-cm abdominal aortic aneurysm with adjacent free intra-abdominal fluid. Two large-bore peripheral intravenous lines are established. Which of the following are the most appropriate next steps in the management of this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Immediate transfer to the operating room for definitive repair; Resuscitation with uncrossmatched blood products to maintain a systolic blood pressure of 80 to 90 mm Hg

Cevap

The correct management consists of immediate transfer to the operating room for definitive repair AND resuscitation with uncrossmatched blood products to maintain a systolic blood pressure of 80 to 90 mm Hg.
This patient is presenting with a ruptured abdominal aortic aneurysm (AAA) complicated by severe hemorrhagic shock. The most appropriate immediate management includes emergent transfer to the operating room for open or endovascular repair and the implementation of permissive hypotension. Permissive hypotension (targeting a systolic blood pressure of 80 to 90 mm Hg) with uncrossmatched blood products ensures adequate end-organ perfusion while minimizing the risk of worsening the hemorrhage by dislodging the fragile retroperitoneal clot. Crystalloids should be minimized to avoid dilutional coagulopathy.

Adım Adım Çözüm

1
Identify the primary diagnosis
Ruptured abdominal aortic aneurysm (AAA)
The patient presents with the classic triad of hypotension, back pain, and a pulsatile abdominal mass, which is immediately confirmed by bedside ultrasound showing a large AAA and free fluid.
2
Assess hemodynamic stability
The patient is in uncompensated hemorrhagic shock
Vital signs show marked hypotension (78/45 mm Hg) and compensatory tachycardia (122/min), alongside signs of poor end-organ perfusion (lethargy, diaphoresis).
3
Determine the appropriate intervention pathway
Emergent surgery and permissive hypotension
Unstable patients with a confirmed AAA rupture must be transported directly to the operating room. Resuscitation should utilize blood products and target a systolic BP of 80-90 mm Hg to maintain vital perfusion while preventing the dislodgement of hemostatic clots.

Anahtar Kavram

Hemodynamically unstable patients with a ruptured abdominal aortic aneurysm identified on bedside ultrasound require immediate operative repair and permissive hypotension with blood products. Advanced imaging (CT) and antihypertensives are contraindicated.
Soru 1714Soru →

A 62-year-old man with a history of a mechanical mitral valve replacement comes to the outpatient clinic for routine coagulation monitoring. Five days ago, he was evaluated at an urgent care center for a purulent skin infection and was started on oral trimethoprim-sulfamethoxazole. His current medications include warfarin, metoprolol, and lisinopril. The patient reports feeling well and denies any epistaxis, hematuria, melena, or easy bruising. Vital signs are within normal limits. Physical examination reveals a healing area of cellulitis on the right lower extremity, with no evidence of petechiae or ecchymoses.

Laboratory results obtained today:
TestResult
Hemoglobin13.813.8 g/dL
Platelets210,000210,000/mm³
Serum creatinine1.11.1 mg/dL
INR7.27.2

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Omit the next 1 to 2 doses of warfarin and repeat the INR in 24 to 48 hours

Cevap

The most appropriate next step is to omit the next 1 to 2 doses of warfarin and repeat the INR in 24 to 48 hours.
In a patient taking warfarin who presents with a supratherapeutic INR between 4.54.5 and 10.010.0 and no evidence of bleeding, the most appropriate management is to omit the next 11 to 22 doses of warfarin, monitor the INR closely, and resume therapy at an appropriately adjusted (lower) dose once the INR falls into the therapeutic range. The target INR for a mechanical mitral valve is typically 2.52.5 to 3.53.5. The recent initiation of trimethoprim-sulfamethoxazole caused this derangement via inhibition of CYP2C9, which metabolizes warfarin. Because there is no active bleeding, the administration of active reversal agents is not indicated.

Adım Adım Çözüm

1
Evaluate the patient for signs of active or life-threatening bleeding.
The patient is completely asymptomatic with no signs of bleeding on history or physical examination.
The presence of major bleeding dictates an immediate shift toward active reversal agents (e.g., prothrombin complex concentrate, FFP, intravenous vitamin K).
2
Identify the cause of the laboratory derangement.
The patient was recently started on trimethoprim-sulfamethoxazole.
Trimethoprim-sulfamethoxazole inhibits the cytochrome P450 2C9 (CYP2C9) enzyme, which decreases the clearance of the more active S-enantiomer of warfarin, significantly elevating the INR.
3
Apply guideline-directed management for the specific INR range.
The INR is 7.2 (which falls into the 4.5 to 10.0 range).
For an asymptomatic patient with an INR between 4.5 and 10.0, current guidelines recommend holding 1 to 2 doses of warfarin and monitoring closely, without administering routine vitamin K.

Anahtar Kavram

Management of supratherapeutic INR in asymptomatic patients
Soru 1715Soru →

An ambulatory care appointment is scheduled for a 64-year-old male patient who is being managed for chronic heart failure with reduced ejection fraction (HFrEF). Over the past three months, he has noticed a progressive decline in his exercise tolerance and now experiences shortness of breath when walking up a single flight of stairs, consistent with New York Heart Association (NYHA) class III symptoms. His current daily medication regimen comprises lisinopril 40 mg, metoprolol succinate 100 mg, and spironolactone 25 mg. In the clinic, his blood pressure measures 128/82 mmHg128/82 \text{ mmHg} and heart rate is 68/min68 \text{/min}. The physical examination is notable for mild jugular venous distention and trace bilateral lower extremity edema. A recent echocardiogram confirms a left ventricular ejection fraction of 32%32\%. Serum laboratory analysis reveals a potassium level of 4.6 mEq/L4.6 \text{ mEq/L} and an estimated glomerular filtration rate of 58 mL/min/1.73 m258 \text{ mL/min/1.73 m}^2. The treating physician plans to escalate his heart failure pharmacotherapy by replacing his current renin-angiotensin system inhibitor with sacubitril-valsartan. Which of the following is the most appropriate strategy for executing this pharmacologic transition?

Cevabı ve açıklamayı göster

Cevap: Discontinue lisinopril and wait at least 36 hours before administering the first dose of sacubitril-valsartan

Cevap

The most appropriate strategy is to discontinue the ACE inhibitor (lisinopril) and wait at least 36 hours before administering the first dose of the ARNI (sacubitril-valsartan).
The correct strategy involves discontinuing the ACE inhibitor (lisinopril) and enforcing a strict 36-hour washout period before initiating the ARNI (sacubitril-valsartan). Sacubitril is a neprilysin inhibitor. Neprilysin is an enzyme responsible for degrading several vasoactive peptides, including bradykinin. ACE inhibitors also block the degradation of bradykinin. If an ARNI is initiated while an ACE inhibitor is still active in the patient's system, the dual inhibition of bradykinin breakdown leads to a rapid and profound accumulation of bradykinin. This synergistic effect dramatically increases the risk of severe, potentially life-threatening angioedema. Therefore, clinical guidelines mandate at least a 36-hour gap between the last dose of an ACE inhibitor and the first dose of an ARNI. Notably, this washout period is not required when transitioning from an Angiotensin Receptor Blocker (ARB) to an ARNI, as ARBs do not affect bradykinin metabolism.

Adım Adım Çözüm

1
Identify the patient's current clinical status and medication regimen.
The patient has symptomatic HFrEF (NYHA class III) despite therapy with an ACE inhibitor (lisinopril), a beta-blocker, and a mineralocorticoid receptor antagonist.
Establishing the baseline helps determine the indication for escalating therapy to an Angiotensin Receptor-Neprilysin Inhibitor (ARNI).
2
Recognize the specific pharmacologic transition being planned.
The physician is replacing lisinopril with sacubitril-valsartan.
The combination of these specific drug classes introduces unique and dangerous pharmacokinetic interactions.
3
Apply the safety guidelines for initiating an ARNI in a patient currently taking an ACE inhibitor.
A mandatory 36-hour washout period must be observed between the last dose of lisinopril and the first dose of sacubitril-valsartan.
Both ACE inhibitors and neprilysin inhibitors decrease the breakdown of bradykinin. Overlapping their effects causes a synergistic accumulation of bradykinin, significantly increasing the risk of potentially fatal angioedema.

Anahtar Kavram

When transitioning a patient from an Angiotensin-Converting Enzyme (ACE) inhibitor to an Angiotensin Receptor-Neprilysin Inhibitor (ARNI), a strict 36-hour washout period is required to minimize the risk of severe angioedema.
Soru 1716Soru →

Match each patient's clinical presentation with the most appropriate next step in their diagnostic workup.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A previously healthy 52-year-old mechanic develops sudden, severe swelling and erythema in his right knee, accompanied by a temperature of 38.2°C (100.8°F).
A 35-year-old teacher with a recently identified positive antinuclear antibody (ANA) titer seeks further assessment for new-onset symmetric polyarthritis, a facial malar rash, and recurrent oral aphthous ulcers.
A 28-year-old software developer describes a progressive six-month history of lumbar pain that is most severe upon awakening, improves after morning exercise, and frequently disrupts his sleep.
A 45-year-old graphic designer complains of worsening pain in both wrists and the small joints of her hands, reporting that her joints feel profoundly stiff for over two hours every morning.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings align acute monoarthritis with arthrocentesis, suspected systemic lupus erythematosus with anti-dsDNA/anti-Smith antibodies, inflammatory back pain with sacroiliac radiography, and suspected rheumatoid arthritis with RF/anti-CCP serologies.
Each correct pairing reflects the guideline-directed initial diagnostic approach based on the specific rheumatologic phenotype. Acute monoarthritis requires definitive fluid analysis via arthrocentesis. Suspected SLE with a positive screening ANA requires specific confirmatory serologies. Inflammatory back pain necessitates targeted imaging of the sacroiliac joints. Symmetric polyarthritis with prolonged stiffness requires classic rheumatoid serologies for confirmation.

Adım Adım Çözüm

1
Analyze the patient presenting with an acutely swollen, red, and febrile knee.
Identify this presentation as a potential joint-threatening infection (septic arthritis).
Before considering less invasive testing, septic arthritis must be definitively ruled out via arthrocentesis to prevent irreversible joint destruction.
2
Evaluate the patient with a positive ANA and clinical signs of systemic lupus erythematosus.
Sequence the diagnostic workup toward highly specific confirmatory tests.
An ANA test is an initial screening tool; anti-double-stranded DNA and anti-Smith antibodies are necessary to secure the diagnosis of SLE due to their high specificity.
3
Assess the young male with chronic back pain that improves with exercise.
Recognize the inflammatory pattern indicative of axial spondyloarthritis.
The initial diagnostic step for suspected ankylosing spondylitis or axial spondyloarthritis relies on objective imaging evidence of inflammation in the sacroiliac joints.
4
Evaluate the patient with symmetric polyarthritis and prolonged morning stiffness.
Identify a high pre-test probability for rheumatoid arthritis.
Guideline-directed evaluation for rheumatoid arthritis begins with obtaining rheumatoid factor and anti-CCP levels to aid in both diagnosis and prognostic assessment.

Anahtar Kavram

Diagnostic test sequencing for rheumatologic conditions prioritizes the urgent exclusion of joint-threatening infections, followed by the targeted use of specific serologies and imaging dictated by the distinct clinical phenotype.
Soru 1717Soru →

A 72-year-old woman is preparing for discharge after a 4-day hospitalization for community-acquired pneumonia. She is clinically stable but has new-onset weakness and requires assistance with activities of daily living. Arrange the following steps of the discharge planning and care transition process in the most appropriate chronological sequence to ensure safe disposition and minimize readmission risk.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Confirm clinical stability, 2) Assess functional capacity to determine disposition, 3) Perform medication reconciliation, 4) Coordinate post-discharge resources, and 5) Deliver structured discharge instructions.
Safe and effective care transitions require a systematic approach to discharge planning. The process must begin with confirming the patient's medical stability, as an unstable patient is not a candidate for discharge. Once stability is established, the team must assess the patient's functional and social needs to determine the appropriate disposition (e.g., home vs. skilled nursing facility). Following the disposition decision, medication reconciliation is performed to finalize the medical plan. Next, the logistics of the discharge are arranged, including follow-up appointments and necessary equipment. Finally, the completed plan is communicated to the patient and family using the teach-back method to ensure comprehension immediately prior to departure.

Adım Adım Çözüm

1
Determine if the patient is medically ready for discharge.
Confirm clinical stability by evaluating vital signs and response to therapy.
A patient cannot safely transition to a lower level of care if they are still acutely unstable.
2
Identify the appropriate post-acute care destination.
Assess functional capacity and social support to determine the care setting.
The disposition location drives the rest of the logistical planning and medication needs.
3
Finalize the medical treatment plan.
Perform comprehensive medication reconciliation.
Discrepancies must be resolved before creating discharge prescriptions and finalized instructions.
4
Arrange logistical support for the chosen disposition.
Coordinate post-discharge resources, follow-up appointments, and equipment.
This ensures continuity of care and safety in the chosen post-acute setting.
5
Educate the patient and confirm understanding.
Deliver structured discharge instructions utilizing the teach-back method.
Patient comprehension of the finalized plan is critical to prevent adverse events and readmissions immediately prior to departure.

Anahtar Kavram

Chronological sequence of safe hospital discharge and care transitions
Soru 1718Soru →

A 34-year-old woman is brought to the emergency department by paramedics following a high-speed motor vehicle collision. On arrival, she is unresponsive and has a Glasgow Coma Scale score of 6 (E1, V1, M4). She has obvious blunt trauma to her abdomen with extensive ecchymosis across her lower quadrants.

Vital signs are:
* Temperature: 35.8°C (96.4°F)
* Heart rate: 142/min
* Blood pressure: 68/38 mm Hg
* Respiratory rate: 8/min and shallow
* Oxygen saturation: 84% on room air

Arrange the following initial stabilization and management steps in the most appropriate sequential order.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence follows the ATLS primary survey: first secure the airway with endotracheal intubation, then establish bilateral large-bore IV access, administer uncrossmatched O-negative blood, perform a bedside FAST exam to locate the bleeding, and finally transfer the patient to the operating room for definitive surgical hemostasis.
The correct sequence strictly adheres to the Advanced Trauma Life Support (ATLS) primary survey protocol: Airway, Breathing, Circulation, Disability, and Exposure. In an unstable trauma patient, the airway must be secured first, followed immediately by establishing access and initiating resuscitation for circulatory collapse. Diagnostic adjuncts (like FAST) occur during or immediately after the primary survey to guide the ultimate step: definitive surgical care.

Adım Adım Çözüm

1
Assess and secure the airway.
Perform endotracheal intubation.
The patient is hypoxic with a respiratory rate of 8/min and a GCS of 6, indicating impending respiratory failure and an inability to protect her airway. This must be addressed before any circulatory interventions.
2
Assess circulation and establish vascular access.
Establish bilateral large-bore peripheral intravenous lines.
Severe hypotension and tachycardia indicate class IV hemorrhagic shock. Adequate vascular access is the prerequisite for life-saving volume resuscitation.
3
Initiate volume resuscitation.
Administer uncrossmatched type O-negative packed red blood cells.
The patient requires immediate restoration of intravascular volume and oxygen-carrying capacity. Blood products are superior to crystalloids in profound hemorrhagic shock.
4
Identify the source of hemorrhage.
Perform a bedside focused assessment with sonography for trauma (FAST).
As an adjunct to the primary survey, a FAST exam quickly identifies intra-abdominal free fluid, directing the surgical team without removing the patient from the resuscitation bay.
5
Provide definitive hemorrhage control.
Transfer to the operating room for an exploratory laparotomy.
Medical resuscitation is only a bridge to surgical hemostasis in trauma patients with massive internal bleeding. The OR is the ultimate destination for definitive stabilization.

Anahtar Kavram

Advanced Trauma Life Support (ATLS) Primary Survey Sequence (ABCDE)
Soru 1719Soru →

A 58-year-old man comes to the cardiology clinic for a routine follow-up visit. He was diagnosed with ischemic cardiomyopathy and heart failure with reduced ejection fraction two years ago. Over the last two months, the patient reports increasing exertional dyspnea; he now becomes short of breath after walking up a single flight of stairs. His current medications include enalapril, carvedilol, spironolactone, and dapagliflozin. He is compliant with his medication regimen and a low-sodium diet. His blood pressure is 118/76 mmHg, and his heart rate is 68/min. Physical examination reveals clear lungs to auscultation bilaterally, no jugular venous distention, and trace bilateral pedal edema. Laboratory studies show a serum sodium of 138 mEq/L, potassium of 4.6 mEq/L, and creatinine of 1.2 mg/dL. The physician decides to replace the patient's angiotensin-converting enzyme (ACE) inhibitor with an angiotensin receptor-neprilysin inhibitor (ARNI) to further reduce morbidity and mortality. Which of the following is the most appropriate next step in modifying this patient's pharmacologic regimen?

Cevabı ve açıklamayı göster

Cevap: Discontinue enalapril, wait 36 hours, and then initiate sacubitril-valsartan

Cevap

Discontinue enalapril, wait 36 hours, and then initiate sacubitril-valsartan.
The correct intervention requires a 36-hour washout period between the discontinuation of an ACE inhibitor (enalapril) and the initiation of an ARNI (sacubitril-valsartan). Both ACE and neprilysin are enzymes responsible for the degradation of bradykinin. Administering an ARNI while an ACE inhibitor is still active in the patient's system leads to a profound, synergistic accumulation of bradykinin, which significantly increases the risk of life-threatening angioedema. The 36-hour timeframe allows for adequate clearance of the ACE inhibitor.

Adım Adım Çözüm

1
Evaluate the patient's current clinical status and indication for medication change.
The patient has worsening chronic HFrEF (NYHA Class III) despite optimal medical therapy including an ACE inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and SGLT2 inhibitor.
Establishing the clinical indication confirms that upgrading from an ACE inhibitor to an ARNI (sacubitril-valsartan) is the correct guideline-directed step to reduce mortality.
2
Identify the pharmacokinetic and pharmacodynamic interactions involved in transitioning from an ACE inhibitor to an ARNI.
Both ACE inhibitors and neprilysin inhibitors (sacubitril) block the degradation of bradykinin. Overlapping active levels of both drugs cause synergistic bradykinin accumulation.
Understanding this interaction highlights the mechanism behind the severe risk of angioedema.
3
Apply the guideline-mandated transition protocol for this medication switch.
A strict 36-hour washout period is required after the last dose of an ACE inhibitor before the first dose of an ARNI can be safely administered.
This specific time frame allows the ACE inhibitor to clear sufficiently from the system, mitigating the risk of overlapping bradykinin inhibition and subsequent angioedema.

Anahtar Kavram

When transitioning a patient with heart failure from an ACE inhibitor to an ARNI, a 36-hour washout period is strictly required to prevent life-threatening angioedema due to overlapping inhibition of bradykinin degradation.
Soru 1720Soru →

A 33-year-old female schoolteacher schedules a visit at a primary care office due to recurrent, frightening episodes of a racing heart and intense sweating over the last 44 months. During these spells, which typically last 1515 to 2020 minutes before subsiding spontaneously, she also experiences severe, throbbing headaches. She reports having four such distinct episodes in the past 3030 days. Her medical history is unremarkable, and she does not take any prescription or over-the-counter medications. She denies the use of illicit substances, tobacco, or alcohol. During today's visit, she is asymptomatic. Vital signs show a blood pressure of 154/96154/96 mmHg and a heart rate of 9292/min. Physical examination, including a comprehensive cardiovascular and neurologic assessment, reveals no abnormalities. Routine blood work, including a comprehensive metabolic panel and complete blood count, is within normal limits. Which of the following is the most appropriate next step in the diagnostic evaluation?

Cevabı ve açıklamayı göster

Cevap: Measurement of plasma fractionated metanephrines

Cevap

The most appropriate next step is the measurement of plasma fractionated metanephrines (or 24-hour urine fractionated metanephrines) to biochemically confirm a suspected pheochromocytoma.
The correct answer identifies that the initial diagnostic step for a patient presenting with the classic triad of pheochromocytoma (episodic headache, diaphoresis, and tachycardia) along with hypertension is biochemical testing. Measurement of plasma fractionated metanephrines or a 24-hour urine collection for metanephrines offers excellent sensitivity for screening and must precede any imaging studies.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient demonstrates the classic triad of episodic pounding headaches, diaphoresis, and tachycardia in the setting of hypertension, which is highly suspicious for a catecholamine-secreting tumor.
Identifying this specific symptom pattern narrows the differential diagnosis to pheochromocytoma and guides the initial testing strategy.
2
Determine the first step in the diagnostic pathway for pheochromocytoma.
Biochemical testing for excess catecholamines must be performed before any imaging studies.
Following the correct test sequence (biochemical confirmation first, followed by tumor localization) prevents the misinterpretation of non-functioning adrenal masses (incidentalomas) commonly found on imaging.
3
Select the most appropriate specific screening test.
Measurement of plasma fractionated metanephrines.
This test provides high diagnostic sensitivity for detecting pheochromocytoma and is the standard initial non-invasive screening method.

Anahtar Kavram

The diagnostic workup for a suspected pheochromocytoma begins with biochemical confirmation of catecholamine excess (via plasma or 24-hour urine fractionated metanephrines) prior to performing any anatomic imaging.
ÖncekiSayfa 86 / 104Sonraki
Patient Management Alıştırma Soruları — USMLE Step 3 — Sayfa 86 | Examkin